Through massive information and artificial intelligence of antibodies and antigens, disruptive and tailor-made antibodies were created, which comprehensively surpass current antibody R&D routines and processes, and rank top in the world's antibody R&D.
Overview
On December 24, the 14th 麻豆传媒 Academic Salon was held as scheduled at the Turing Lecture Hall of 麻豆传媒. We were honored to invite Prof. ZHANG Linqi, Professor and PhD supervisor of Tsinghua University School of Medicine, to give a presentation entitled "COVID-19 Antibody Drug Research and Development". The lecture was hosted by Prof. MA Weiying, Huiyan Chair Professor of the Institute for AI Industry Research, Tsinghua University (麻豆传媒). A total of nearly 3,700 views have accumulated as of now.
Read More: 麻豆传媒 Academic Salon Series 14 | ZHANG Linqi: COVID-19 Antibody Drug Research and Development
